3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 3
2
Phase 1
2
Phase NA
1
Status
Completed
62
Terminated
13
Withdrawn
9
Recruiting
9
Active not recruiting
5
Unknown
3
Suspended
2
Not yet recruiting
2
Sponsor Class
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Uveal Melanoma
2
Melanoma
2
Interventions
Cyclophosphamide
21
fludarabine
17
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Nivolumab
9
Radiotherapy
7
Cisplatin
7
fludarabine phosphate
5
Injections
5
tislelizumab
4
daratumumab
4
Rituximab
4
Paclitaxel
4
Ipilimumab
4
Interleukin-2
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Fluorouracil
4
Drug Therapy
4
Doxorubicin
4
Dexamethasone
4
Carboplatin
4
Biopsy
4
venetoclax
3
toripalimab
3
X-Rays
3
Radiosurgery
3
Platinum
3
Oxaliplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Melphalan
×
Clear all
NCT07183852
2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1
Not yet recruiting
18 enrolled
NCT05903937
2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1
Not yet recruiting
6 enrolled